The purpose of this study is to perform a cost-effectiveness analysis of lo
ng-term moderate exercise training (ET) in patients with stable chronic hea
rt failure. In particular, the study focuses on the survival analysis and c
ost savings from the reduction in the hospitalization rate in the exercise
group. In the past 10 years, ET has been shown to be beneficial for patient
s with stable class II and III heart failure in many randomized clinical tr
ials. However, the cost-effectiveness of a long-term ET program has not bee
n addressed for outcomes related to morbidity/mortality end points or healt
h care utilization. We examined the cost-effectiveness of a 14-month longte
rm training in patients with stable chronic heart failure. The estimated in
crement cast for the training group, $3,227/patient, was calculated by subt
racting the averted hospitalization cost, $1,336/patient, from the cost of
ET and wage last due to ET, estimated at $4,563/patient. For patients recei
ving ET, the estimated increment in life expectancy was 1.82 years/person i
n a time period of 15.5 years, compared with patients in the control group.
The cost-effectiveness ratio for long-term ET in patients with stable hear
t failure was thus determined at $1,773/life-year saved, at a 3% discount r
ate. Long-term ET in patients with stable chronic heart failure is cost-eff
ective and prolongs survival by on additional 1.82 years at a low cost of $
1,773 per/life-year saved. (C) 2001 by Excerpta Medico, Inc.